U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07213297) titled 'Comprehensive Program for Hereditary Transthyretin Amyloidosis' on Sept. 05.
Brief Summary: The Comprehensive Program for Hereditary Transthyretin Amyloidosis describes a prospective observational study focused on understanding hereditary transthyretin amyloidosis (ATTR), a progressive and potentially fatal condition marked by amyloid fibril deposits impacting multiple organs. The trial aims to characterize patient phenotypes, investigate factors affecting disease progression, and identify minimum criteria for disease onset. Conducted at Nestor Kirchner Hospital, the trial enrolls participants over 18 years old with confirmed pathoge...